Nephromax
Payments companies reported to CMS as associated with Nephromax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nephromax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nephromax
These are the largest totals companies reported as associated with Nephromax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Carraher | Jackson, TN | Urology | $117.53 |
| Robert Wake | Memphis, TN | Urology | $117.53 |
| Christopher Ledbetter | Memphis, TN | Urology | $117.53 |
| Ava Saidian | San Diego, CA | Urology | $117.53 |
| Aaron Bloch | Murrieta, CA | Urology | $117.53 |
| Joel Abbott | Las Vegas, NV | Urology | $34.35 |
| Adam Bezinque | Grand Rapids, MI | Urology | $23.35 |
| Jeffrey Sparenborg | Provo, UT | Urology | $20.05 |
| Hariharan Palayapalayam Ganapathi | Tampa, FL | Urology | $18.83 |
| Richard Mcwhorter | Fayetteville, AR | Urology | $18.70 |
Prescribed Nephromax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.